CCR5 blockade in rheumatoid arthritis: A randomised, double-blind, placebo-controlled clinical trial. Commentary

Tom Huizinga*, Peter Nigrovic, Eric Ruderman, Hendrik Schulze-Koops

*Corresponding author for this work

Research output: Contribution to journalComment/debatepeer-review

Original languageEnglish (US)
Number of pages1
JournalInternational Journal of Advances in Rheumatology
Volume9
Issue number1
StatePublished - Dec 1 2011

ASJC Scopus subject areas

  • Rheumatology

Cite this